Here Are 2 Space Stocks With Less Risk and More Upside Potential Than SpaceX

Rocket Lab reported Q1 2026 revenue up 63.5% year over year to $200.3 million and backlog of about $2.2 billion, while AST SpaceMobile said Q1 fiscal 2026 revenue was $14.7 million and it aims for $150 million to $200 million in fiscal 2026 sales. Rocket Lab also has a $190 million, 20-launch HASTE order tied to a DoD hypersonic-testing program, and AST launched three more BlueBird satellites, bringing its total launched count to around 10. The piece is constructive on both names versus SpaceX, but it highlights valuation and execution risk.

Analysis

The cleaner read is not “space vs. space,” but infrastructure monetization vs. speculative optionality. ASTS has the more convex setup because every incremental satellite launched can de-risk coverage, uptime, and carrier adoption at the same time, which is why its catalyst path is more legible to the market than a generic hardware story. That said, the valuation already assumes meaningful execution, so the stock is now vulnerable to any gap between launch cadence and commercial conversion over the next 2-4 quarters.

Rocket Lab’s near-term support is more mechanical: index inclusion plus defense-linked backlog can create passive and quasi-passive demand even if fundamentals don’t re-rate immediately. The second-order effect is that any incremental capex or launch delay gets penalized more harshly after inclusion because the buyer base shifts toward liquidity-sensitive holders, not just believers in the story. In other words, the stock may trade better than the business for a while, but that also makes it more fragile on any guidance miss.

The market appears to be underpricing execution asymmetry. ASTS has a higher probability of a sharp upward rerating if it proves real-world throughput, because telecom partnerships create a potential recurring-revenue network effect that scales faster than launch revenue. Conversely, Rocket Lab’s defense exposure is attractive, but much of the good news may already be embedded via backlog visibility; unless Neutron milestones tighten, upside may be more dependent on multiple expansion than fundamental surprise.

The contrarian risk is that both names are being treated like “picks and shovels” when they are still mostly pre-dominant-platform stories. If commercial uptake or launch reliability slips by even a single quarter, the market can quickly compress both names, but ASTS should be more sensitive to operational proof points while RKLB is more sensitive to valuation and flow. The best risk/reward may therefore be to own the one with measurable near-term de-risking and hedge the one whose support is more flow-driven than fundamental.

Key Decisions for Investors

• Long ASTS into the next satellite-launch window, with a 3-6 month horizon; look for a tradeable rerating if coverage metrics and subscriber conversion start validating the network thesis, but size modestly because the stock is still priced for execution.
• Use RKLB as a tactical long only on pullbacks into or just after index-inclusion-related strength; the setup is better for a 1-3 month flow trade than a long-duration compounder at current valuation.
• Pair trade: long ASTS / short RKLB for the next 2-4 quarters if the goal is exposure to a clearer de-risking path and higher upside surprise on commercial proof points versus a name already benefiting from passive demand.
• For options traders, consider ASTS call spreads rather than outright stock to capture launch/coverage upside while limiting drawdown from any commercialization delay over the next 90-180 days.
• Avoid chasing both names after sharp up-days; wait for post-event volatility to rebuild because these are execution-driven equities where the entry point matters more than the narrative.